Ocular Therapeutix OCUL
NASDAQ OCUL
$6.50 -0.11 (-1.66%)
At close: Oct 23, 2026 · 4:00 PM EDT

Ocular Therapeutix (OCUL) Sale and Maturity of Investments (2015 - 2017)

Updated

Analysis

Ocular Therapeutix (OCUL) Sale and Maturity of Investments (2015 - 2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Ocular Therapeutix 1.43 Bn -919.84 Mn 11.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 3.00 Mn
Jun 30, 2017 22.70 Mn
Mar 31, 2017 12.50 Mn
Dec 31, 2016 16.00 Mn
Sep 30, 2016 14.68 Mn
Jun 30, 2016 25.00 Mn
Mar 31, 2016 25.00 Mn
Dec 31, 2015 15.00 Mn
Sep 30, 2015 30.00 Mn
API Access

Ocular Therapeutix Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=OCUL&period=max&api_key=YOUR_API_KEY